Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Carmen Schweighofer
First-Line Treatment of Chronic Lymphocytic Leukemia: Role of Alemtuzumab
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Filgrastim and Alemtuzumab (Campath-1h) for Refractory Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Still a Role for Second-Line Chemoimmunotherapy in Chronic Lymphocytic Leukemia?
Haematologica
Hematology
FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia
Oncologist
Cancer Research
Medicine
Oncology
The Use of Low-Dose Alemtuzumab in Pretreated B-Cell Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?
Therapeutic Advances in Hematology
Hematology
Idelalisib for the Treatment of Chronic Lymphocytic Leukemia
ISRN Oncology
VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (Literature Review)
Oncogematologiya
Oncology
Hematology
Chronic Lymphocytic Leukemia
Current Opinion in Hematology
Hematology
Economic Cost of Adverse Events Per Course of Therapy With Commonly Used First-Line Regimens for the Treatment of Chronic Lymphocytic Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental